McGill to partner with Israeli research institutions
McGill University has signed three important memoranda of understanding this week for collaborative research partnerships with institutions in Israel. The memoranda were signed by Dr. Rose Goldstein, McGill’s Vice-Principal (Research and International Relations), during an economic mission led by Montreal Mayor Gérald Tremblay and co-organized by the Chambre de commerce du Montréal métropolitain and Montréal International.
The memoranda cover the following initiatives:
- renewal of a partnership with Weizmann Institute of Science in cancer research;
- a new agreement with Tel-Aviv University’s Sackler Faculty of Medicine;
- a new agreement with Bar-Ilan University, building on McGill Prof. Moshe Szyf’s groundbreaking work in behavioural epigenetics.
“Increasingly universities need to develop world-class partnerships if they want to be in a position to solve the complex problems facing society,” said Dr. Goldstein. “Internationally, McGill is developing an approach to research that is more entrepreneurial and global. Israel has established very productive partnerships among universities, industry and governments – providing a particularly interesting example for Canada and McGill.”
McGill has enjoyed a highly successful partnership with the Weizmann Institute since 2007, resulting in a number of joint research projects and collaborative activities. The projects have focused on a wide range of cancer research. McGill and Weizmann have also developed collaborations in astrophysics, cosmology and evolutionary biology, which they plan to build on through the new agreement. The Weizmann Institute serves as a meeting place for scientists from different disciplines, setting the stage for multidisciplinary collaborations and the emergence of new research fields.
The Sackler Faculty of Medicine is Israel’s largest institute of higher medical education, with about 1,000 teachers in preclinical departments and in affiliated clinical departments and institutes, located in seven major medical centres, six psychiatric hospitals, and a large rehabilitation centre. Research in Sackler’s preclinical and clinical departments covers most fields of the biomedical sciences.
The goal of the proposed collaborative research activities with Bar-Ilan University – its first agreement with a Canadian institution – is to address the question of how exposures to drug, food, trauma and other life experiences are registered in brain circuitries and the genome as well as how they alter phenotypes, leading to human disease and affliction. Members of both the Bar-Ilan and McGill research groups are widely considered pioneers in these areas.
About McGill University
Founded in Montreal, Que., in 1821, McGill is Canada’s leading post-secondary institution. It has two campuses, 11 faculties, 11 professional schools, 300 programs of study and more than 37,000 students, including 8,300 graduate students. McGill attracts students from over 150 countries around the world, with more than 7,200 international students making up 20 per cent of the student body. Almost half of McGill students claim a first language other than English, including more than 6,200 francophones.
On the Web: www.mcgill.ca